CAMBRIDGE, Mass., Sept. 24, 2016-- Aegerion Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat debilitating rare diseases, ...
- GlobeNewswire•5 days ago
CAMBRIDGE, Mass., Sept. 20, 2016-- Aegerion Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating ...
Aegerion Pharmaceuticals, Inc. (AEGR)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||2.48 x 1000|
|Ask||2.79 x 2000|
|Day's Range||2.61 - 2.82|
|52wk Range||1.23 - 16.63|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-0.51|
|Avg Vol (3m)||349,455|
|Dividend & Yield||N/A (N/A)|